Nothing Special   »   [go: up one dir, main page]

ZA907944B - Hiv related peptides - Google Patents

Hiv related peptides

Info

Publication number
ZA907944B
ZA907944B ZA907944A ZA907944A ZA907944B ZA 907944 B ZA907944 B ZA 907944B ZA 907944 A ZA907944 A ZA 907944A ZA 907944 A ZA907944 A ZA 907944A ZA 907944 B ZA907944 B ZA 907944B
Authority
ZA
South Africa
Prior art keywords
hiv
terminal
related peptides
hiv related
peptides
Prior art date
Application number
ZA907944A
Other languages
English (en)
Inventor
Paul H Naylor
H Naylor Paul
Su Sun Wang
Sun Wang Su
Original Assignee
Univ George Washington
Viral Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23666609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA907944(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ George Washington, Viral Technologies Inc filed Critical Univ George Washington
Publication of ZA907944B publication Critical patent/ZA907944B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA907944A 1989-10-12 1990-10-04 Hiv related peptides ZA907944B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42046989A 1989-10-12 1989-10-12

Publications (1)

Publication Number Publication Date
ZA907944B true ZA907944B (en) 1991-10-30

Family

ID=23666609

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907944A ZA907944B (en) 1989-10-12 1990-10-04 Hiv related peptides

Country Status (17)

Country Link
EP (3) EP0426314B1 (xx)
JP (1) JPH03209398A (xx)
KR (1) KR910007962A (xx)
CN (1) CN1052310A (xx)
AT (1) ATE119166T1 (xx)
AU (1) AU6393990A (xx)
CA (1) CA2027455A1 (xx)
DE (1) DE69017352T2 (xx)
DK (1) DK0426314T3 (xx)
ES (1) ES2071038T3 (xx)
GB (1) GB2236754A (xx)
GR (1) GR3015244T3 (xx)
HU (1) HUT55035A (xx)
IE (1) IE67533B1 (xx)
IL (1) IL95890A0 (xx)
NZ (1) NZ235538A (xx)
ZA (1) ZA907944B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
US6103239A (en) * 1996-08-09 2000-08-15 Cel-Sci Corporation Modified HGP-30 heteroconjugates, compositions and methods of use
NO314588B1 (no) * 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
ATE478089T1 (de) * 2001-08-07 2010-09-15 Medestea Int Spa Isolierte polypeptide auf der grundlage des neutralisierenden epitops des p17-proteins vom hiv geeignet als impfstoffe und neutralisierende anti-p17-antikörper, die besagtes epitop spezifisch erkennen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3687A (da) * 1986-01-06 1987-07-07 Hoffmann La Roche Polypeptider og fremgangsmaade til fremstilling deraf
ZA873215B (en) * 1986-05-19 1987-10-28 Viral Technologies Inc. Htlv-iii/lav virus related peptides,antibodies to the peptides,vaccines,passive and active immunization against aids virus and diagnostic test for the serological detection of aids virus
EP0273716B1 (en) * 1986-12-30 1993-08-11 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
DK643188A (da) * 1987-11-24 1989-05-25 Smithkline Biolog Ekspression af hiv-proteiner i e.coli og s.cerevisiae
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection

Also Published As

Publication number Publication date
CA2027455A1 (en) 1991-04-13
DE69017352D1 (de) 1995-04-06
NZ235538A (en) 1992-06-25
EP0426314B1 (en) 1995-03-01
EP0620009A1 (en) 1994-10-19
DK0426314T3 (da) 1995-03-27
JPH03209398A (ja) 1991-09-12
AU6393990A (en) 1991-04-18
ES2071038T3 (es) 1995-06-16
GB2236754A (en) 1991-04-17
DE69017352T2 (de) 1995-10-05
EP0426314A3 (en) 1991-07-24
IL95890A0 (en) 1991-07-18
EP0620010A1 (en) 1994-10-19
ATE119166T1 (de) 1995-03-15
GB9021942D0 (en) 1990-11-21
GR3015244T3 (en) 1995-06-30
CN1052310A (zh) 1991-06-19
EP0426314A2 (en) 1991-05-08
KR910007962A (ko) 1991-05-30
HU906421D0 (en) 1991-04-29
HUT55035A (en) 1991-04-29
IE903604A1 (en) 1991-04-24
IE67533B1 (en) 1996-04-03

Similar Documents

Publication Publication Date Title
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
AU1353295A (en) Peptides derived from a retrovirus of the HIV group, and their use
DE68928130D1 (de) Synthetische vom HIV-GP120-env-Protein abgeleitete Peptide und ihre Anwendung
AU5376201A (en) Methods and compositions for impairing multiplication of hiv-1
IL95742A (en) Recombinant polypeptides and peptides nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
US4755380A (en) Peptide from amyloid A and antiserum therefor
EP0426314A3 (en) Hiv related peptides
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
EP0330700A4 (en) Human prourokinase-like polypeptide.
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
GB2299994B (en) Equine arteritis virus peptides; antibodies and their use in a diagnostic test
PT87239A (pt) Process for the preparation of peptides
TH9844A (th) เพพไทด์ที่สัมพันธุ์ hiv
HUP9900766A2 (hu) Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez
TH9844EX (th) เพพไทด์ที่สัมพันธุ์ hiv
WO1991009872A3 (en) Hiv-1 env fragment fusion protein